FWM
INSM icon

Focused Wealth Management’s Insmed INSM Stock Holding History

Focused Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,400
Closed -$50.6K – 1070
2023
Q2 		$50.6K Hold
2,400
– – 0.01% 301
2023
Q1 		$40.9K Hold
2,400
– – 0.01% 335
2022
Q4 		$48K Hold
2,400
– – 0.01% 313
2022
Q3 		$52K Buy
+2,400
New +$57.5K 0.01% 272

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Focused Wealth Management's INSM Position: Q3 2023 in Review

Focused Wealth Management sold out of Insmed (INSM) in Q3 2023, closing a stake of 2,400 shares — an estimated $50.6K sold.

Focused Wealth Management first reported a position in INSM in Q3 2022 and held it in 4 quarters. The position peaked at $52K in Q3 2022. 252 funds tracked by Wall St. Rank hold INSM as of Q3 2023.

  • Focused Wealth Management reported no remaining Insmed position as of Q3 2023 after selling out during the quarter.
  • Focused Wealth Management sold 2,400 Insmed shares in Q3 2023, an estimated $50.6K.
  • Focused Wealth Management first reported a position in Insmed in Q3 2022 and held it in 4 quarters.
  • Focused Wealth Management's Insmed position peaked at $52K in Q3 2022.
  • 252 funds tracked by Wall St. Rank held Insmed as of Q3 2023.

Based on Focused Wealth Management's 13F filing for Q3 2023, filed 1 Nov 2023.